Floatz logo

Phenoxodiol

Peritoneal Neoplasms

MEI Pharma, Inc.Phase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Peritoneal Neoplasms cohort.

Asset / SponsorPhaseRating
Carboplatin
Eli Lilly and Company
Phase 3BBB
Inno-206
Eli Lilly and Company
Phase 3BBB
Hycamtin
Eli Lilly and Company
Phase 3BB
Eloxatin
Sun Yat-sen University
Phase 2/3BB
Patupilone
Novartis Pharmaceuticals
Phase 3BB

View all 44 →

Same molecule, other indications

Phenoxodiol is also rated in:

fallopian tube cancerDormant
B
Indicative ·
59 / 100
View asset →
ovarian cancerDormant
B
Indicative ·
57 / 100
View asset →
primary peritoneal carcinomaDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →